Kevin M. Slawin
InvestorFounderManaging Partner at Rapha Capital Management, LLC · Executive at Eos SENOLYTIX · Member of the Board of Directors at K2 Biolabs · Founder at FIZE Medical, Inc.
Miami Beach, Florida
Writes $100K – $10M checks · typically $100K
About
Founder and Managing Partner of Rapha Capital Management, an oncologic and robotic surgeon, biotech investor, and founder focused on oncology, T cells, and immunotherapy. He founded Bellicum Pharmaceuticals (NASDAQ: BLCM), which completed a successful IPO in 2014, and serves on the boards of several portfolio companies including 3DBio Therapeutics, FIZE Medical, Demeetra AgBio, and Imagin Medical.
Contact· self-published, not guessed
Executive at Eos SENOLYTIX
Intro paths
In turn, Kevin can intro founders to Eos SENOLYTIX's investors below.
Eos SENOLYTIX's investors · 1
Member of the Board of Directors at K2 Biolabs
Intro paths
In turn, Kevin can intro founders to K2 Biolabs's investors below.
K2 Biolabs's investors · 1
Founder at FIZE Medical, Inc.
Intro paths
In turn, Kevin can intro founders to FIZE Medical, Inc.'s investors below.
FIZE Medical, Inc.'s investors · 1
Experience
- GEROTHERAPEUTIX, Inc.Chairman, Founder and CEOcurrent2024 — presentHouston, TX
- Eos SENOLYTIX, Inc.Chairman, Founder and CEOcurrent2024 — presentHouston, TX
- Phoenix SENOLYTIX, Inc.Chairman, Founder and CEOcurrent2024 — presentHouston, Texas, United States
- Perseus SENOLYTIXChairman, Founder and CEOcurrent2024 — presentHouston, Texas, United States
- Ponce Aurora, Inc.Chairman, Founder and CEOcurrent2024 — presentMiami, Florida, United States
- PrintBio, Inc.Chairman, Founder and CEOcurrent2023 — presentNew York City Metropolitan Area
- DELIVER Therapeutics, Inc.Founder, CEO and Chairmancurrent2021 — presentHouston, Texas, United States
- FIZE MedicalChairman of the Boardcurrent2022 — presentModiin, Central, Israel
- FIZE MedicalBoard Member2020 — 2022Modiin, Central, Israel
- Miami MediCosFounder and Chairmancurrent2021 — presentMiami Beach, Florida, United States
- Imagin MedicalChairman of the Boardcurrent2021 — present
- K2 BiolabsFounding Board Membercurrent2021 — presentHouston, Texas, United States
- COVID Rapid Test - Texas, LLCCo-Founder, Managing Member and CMOcurrent2020 — presentHouston, Texas, United States
- COVID Rapid Ab Test, LLCFounder, CEO and Medical Directorcurrent2020 — presentMiami Beach, Florida, United States
- Rapha Capital Management, LLCFounder and Managing Partnercurrent2018 — presentMiami Beach, Florida, United States
- Bellicum Pharmaceuticals, Inc.Foundercurrent2004 — presentHouston, Texas Area
- Bellicum Pharmaceuticals, Inc.Founder and Chief Technology Officer2014 — 2017houston, texas
- Bellicum Pharmaceuticals, Inc.Founder and Director2004 — 2017
- Bellicum Pharmaceuticals, Inc.Founder, Executive Chairman, and Chief Medical Officer2004 — 2014texas medical center, houston, tx
- Demeetra AgBio, Inc.Board Member2020 — 2025Kentucky, United States
- Vanguard Urologic InstituteFounder2007 — 2019Memorial Hermann - Texas Medical Center
- Memorial Hermann Healthcare SystemDirector of Urology - MMH TMC2007 — 2017Houston, TX
- Baylor College of MedicineDirector, The Baylor Prostate Center1994 — 2007
Skills & more
+8 more
Medical DiagnosticsOncologyImmunologyPharmaceutical IndustryLife SciencesBiotechnologyClinical DevelopmentClinical ResearchFrom Kevin's professional profile.
Deals · 22
Eos SENOLYTIXSolo GP
via Rapha Capital Management, LLC · filed Jun 2026
Imagin Medical, Inc.Solo GP
via Rapha Capital Management, LLC · filed Oct 2020
DelivertheraSolo GP
K2 BiolabsSolo GP
NexImmuneSolo GP
Ponce AuroraSolo GP
PrintBioSolo GP
SENOTHERAPEUTIXSolo GP
SightlySolo GP
3DBIOSolo GP
BellicumSolo GP
Bellicum Pharmaceutical, Inc.Solo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Frequently asked questions
- Who is Kevin M. Slawin?
- Founder and Managing Partner of Rapha Capital Management, an oncologic and robotic surgeon, biotech investor, and founder focused on oncology, T cells, and immunotherapy. He founded Bellicum Pharmaceuticals (NASDAQ: BLCM), which completed a successful IPO in 2014, and serves on the boards of several portfolio companies including 3DBio Therapeutics, FIZE Medical, Demeetra AgBio, and Imagin Medical.
- Where does Kevin M. Slawin work?
- Kevin M. Slawin is Founder of DELiver Therapeutics and Managing Partner at Rapha Capital Management, LLC and Executive at Eos SENOLYTIX and Member of the Board of Directors at K2 Biolabs and Founder at FIZE Medical, Inc..
- What check size does Kevin M. Slawin write?
- Kevin M. Slawin typically writes checks of $100K – $10M.
- What companies did Kevin M. Slawin found?
- Kevin M. Slawin founded DELiver Therapeutics, FIZE Medical, Inc..
- Where did Kevin M. Slawin go to school?
- Kevin M. Slawin studied at Columbia University Vagelos College of Physicians and Surgeons (M.D.); Columbia University (B.A., Biochemistry).
Founder mafias
Columbia University mafia200
Also came through, then founded or led a company.
+ 193 more
Columbia University Vagelos College of Physicians and Surgeons mafia5
Also came through, then founded or led a company.
Same school
Also attended Columbia University Vagelos College of Physicians and Surgeons15
+ 9 more
Also attended Columbia University726
+ 720 more
Shared employers
Also worked at Baylor College of Medicine28
+ 22 more